BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 23824593)

  • 1. Extrathymic induction of Foxp3⁺ regulatory T cells declines with age in a T-cell intrinsic manner.
    Carpentier M; Chappert P; Kuhn C; Lalfer M; Flament H; Burlen-Defranoux O; Lantz O; Bandeira A; Malissen B; Davoust J; Gross DA
    Eur J Immunol; 2013 Oct; 43(10):2598-604. PubMed ID: 23824593
    [TBL] [Abstract][Full Text] [Related]  

  • 2. "Default" generation of neonatal regulatory T cells.
    Wang G; Miyahara Y; Guo Z; Khattar M; Stepkowski SM; Chen W
    J Immunol; 2010 Jul; 185(1):71-8. PubMed ID: 20498359
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aurintricarboxylic acid promotes the conversion of naive CD4+CD25- T cells into Foxp3-expressing regulatory T cells.
    Lim DG; Park YH; Kim SE; Kim YH; Park CS; Kim SC; Park CG; Han DJ
    Int Immunol; 2011 Sep; 23(9):583-92. PubMed ID: 21750147
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TGF-beta1 modulates Foxp3 expression and regulatory activity in distinct CD4+ T cell subsets.
    Pyzik M; Piccirillo CA
    J Leukoc Biol; 2007 Aug; 82(2):335-46. PubMed ID: 17475784
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sub-optimal CD4+ T-cell activation triggers autonomous TGF-β-dependent conversion to Foxp3+ regulatory T cells.
    Oliveira VG; Caridade M; Paiva RS; Demengeot J; Graca L
    Eur J Immunol; 2011 May; 41(5):1249-55. PubMed ID: 21469093
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Costimulation blockade-induced cardiac allograft tolerance: inhibition of T cell expansion and accumulation of intragraft cD4(+)Foxp3(+) T cells.
    Oderup C; Malm H; Ekberg H; Qi Z; Veress B; Ivars F; Corbascio M
    Transplantation; 2006 Dec; 82(11):1493-500. PubMed ID: 17164722
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD8+ Foxp3+ T cells share developmental and phenotypic features with classical CD4+ Foxp3+ regulatory T cells but lack potent suppressive activity.
    Mayer CT; Floess S; Baru AM; Lahl K; Huehn J; Sparwasser T
    Eur J Immunol; 2011 Mar; 41(3):716-25. PubMed ID: 21312192
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of immunosuppressive drug rapamycin on regulatory CD4+CD25+Foxp3+T cells in mice.
    Qu Y; Zhang B; Zhao L; Liu G; Ma H; Rao E; Zeng C; Zhao Y
    Transpl Immunol; 2007 Apr; 17(3):153-61. PubMed ID: 17331841
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased CD4+CD25+Foxp3+ regulatory T cells in tolerance induced by portal venous injection.
    He F; Chen Z; Xu S; Cai M; Wu M; Li H; Chen X
    Surgery; 2009 Jun; 145(6):663-74. PubMed ID: 19486771
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vivo expansion of CD4+Foxp3+ regulatory T cells mediated by GITR molecules.
    Nishioka T; Nishida E; Iida R; Morita A; Shimizu J
    Immunol Lett; 2008 Dec; 121(2):97-104. PubMed ID: 18930767
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induced peripheral regulatory T cells: the family grows larger.
    Höglund P
    Eur J Immunol; 2006 Feb; 36(2):264-6. PubMed ID: 16453386
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Are regulatory T-cells linked with aging?
    Dejaco C; Duftner C; Schirmer M
    Exp Gerontol; 2006 Apr; 41(4):339-45. PubMed ID: 16516426
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Loss of FOXP3 expression in natural human CD4+CD25+ regulatory T cells upon repetitive in vitro stimulation.
    Hoffmann P; Boeld TJ; Eder R; Huehn J; Floess S; Wieczorek G; Olek S; Dietmaier W; Andreesen R; Edinger M
    Eur J Immunol; 2009 Apr; 39(4):1088-97. PubMed ID: 19283780
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recent thymic origin, differentiation, and turnover of regulatory T cells.
    Mabarrack NH; Turner NL; Mayrhofer G
    J Leukoc Biol; 2008 Nov; 84(5):1287-97. PubMed ID: 18682578
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peripheral T-cell tolerance associated with prostate cancer is independent from CD4+CD25+ regulatory T cells.
    Degl'Innocenti E; Grioni M; Capuano G; Jachetti E; Freschi M; Bertilaccio MT; Hess-Michelini R; Doglioni C; Bellone M
    Cancer Res; 2008 Jan; 68(1):292-300. PubMed ID: 18172322
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The significantly enhanced frequency of functional CD4+CD25+Foxp3+ T regulatory cells in therapeutic dose aspirin-treated mice.
    Javeed A; Zhang B; Qu Y; Zhang A; Sun C; Zhang L; Liu J; Zeng C; Zhao Y
    Transpl Immunol; 2009 Mar; 20(4):253-60. PubMed ID: 19146957
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Conversion of peripheral CD4+CD25- naive T cells to CD4+CD25+ regulatory T cells by TGF-beta induction of transcription factor Foxp3.
    Chen W; Jin W; Hardegen N; Lei KJ; Li L; Marinos N; McGrady G; Wahl SM
    J Exp Med; 2003 Dec; 198(12):1875-86. PubMed ID: 14676299
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Changes of CD4+CD25+Foxp3+ regulatory T cells in aged Balb/c mice.
    Zhao L; Sun L; Wang H; Ma H; Liu G; Zhao Y
    J Leukoc Biol; 2007 Jun; 81(6):1386-94. PubMed ID: 17369496
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of induced versus natural regulatory T cells of the same TCR specificity for induction of tolerance to an environmental antigen.
    Huang H; Ma Y; Dawicki W; Zhang X; Gordon JR
    J Immunol; 2013 Aug; 191(3):1136-43. PubMed ID: 23817420
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cutting edge: Intrathymic differentiation of adaptive Foxp3+ regulatory T cells upon peripheral proinflammatory immunization.
    Zelenay S; Bergman ML; Paiva RS; Lino AC; Martins AC; Duarte JH; Moraes-Fontes MF; Bilate AM; Lafaille JJ; Demengeot J
    J Immunol; 2010 Oct; 185(7):3829-33. PubMed ID: 20817879
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.